tiprankstipranks
Advertisement
Advertisement

CLLS Stock Latest News

Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
Company AnnouncementsCellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
8h ago
6K
CLLS
Cellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
PremiumCompany Announcements
Cellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
20h ago
6K
CLLS
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
PremiumThe Fly
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
9d ago
CLLS
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
PremiumCompany Announcements
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
9d ago
6K
CLLS
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
PremiumThe Fly
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
10d ago
CLLS
Cellectis sees cash runway into 4Q27
PremiumThe FlyCellectis sees cash runway into 4Q27
10d ago
CLLS
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
Premium
Company Announcements
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
10d ago
6K
CLLS
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
Premium
Company Announcements
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
10d ago
6K
CLLS
CLLS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLLS Earnings this Week: How Will it Perform?
12d ago
CLLS
Cellectis to Release First-Quarter 2026 Results on May 11
PremiumCompany Announcements
Cellectis to Release First-Quarter 2026 Results on May 11
17d ago
6K
CLLS
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
PremiumCompany Announcements
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
24d ago
6K
CLLS
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
PremiumCompany Announcements
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
1M ago
6K
CLLS
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
PremiumThe FlyCellectis highlights Allogene ALPHA3 trial data, potential milestone payments
1M ago
ALLO
CLLS
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
Premium
Company Announcements
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
2M ago
6K
CLLS
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
Premium
Company Announcements
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
2M ago
6K
CLLS
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CLLS
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
PremiumCompany Announcements
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
4M ago
6K
CLLS
Cellectis initiated with a Buy at Clear Street
PremiumThe Fly
Cellectis initiated with a Buy at Clear Street
5M ago
CLLS
Cellectis Announces Arbitral Decision in Servier Dispute
PremiumCompany Announcements
Cellectis Announces Arbitral Decision in Servier Dispute
5M ago
6K
CLLS
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
PremiumThe FlyAllogene Therapeutics says favorable result for Servier in Cellectis arbitration
5M ago
ALLO
CLLS
Cellectis announces arbitral decision in dispute with Servier
Premium
The Fly
Cellectis announces arbitral decision in dispute with Servier
5M ago
CLLS
Cellectis Unveils Promising Phase 1 Results for Eti-cel at ASH 2025
Premium
Company Announcements
Cellectis Unveils Promising Phase 1 Results for Eti-cel at ASH 2025
5M ago
6K
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >